Order Article Reprints

Karuniawati A, Ambarwulan M, Shahab SN, Moenadjat Y, Lalisang TJM, Kurniati ND, Kuntaman, Budipramana VS, Lesmana T, Puspitasari I, et al. Ceftolozane/Tazobactam In-Vitro Activity against Clinical Isolates from Complicated Intra-Abdominal Infection Patients in Three Indonesian Referral Hospitals. Antibiotics. 2023; 12(1):52. https://doi.org/10.3390/antibiotics12010052

Karuniawati, Anis, Merry Ambarwulan, Selvi Nafisa Shahab, Yefta Moenadjat, Toar J. M. Lalisang, Neneng Dewi Kurniati, Kuntaman, Vicky Sumarki Budipramana, Tomy Lesmana, Iva Puspitasari, and et al. 2023. "Ceftolozane/Tazobactam In-Vitro Activity against Clinical Isolates from Complicated Intra-Abdominal Infection Patients in Three Indonesian Referral Hospitals" Antibiotics 12, no. 1: 52. https://doi.org/10.3390/antibiotics12010052

Karuniawati, A., Ambarwulan, M., Shahab, S. N., Moenadjat, Y., Lalisang, T. J. M., Kurniati, N. D., Kuntaman, Budipramana, V. S., Lesmana, T., Puspitasari, I., Prabowo, E., Sasmitasari, D. P. C., Putri, D. O., & Badawi, A. (2023). Ceftolozane/Tazobactam In-Vitro Activity against Clinical Isolates from Complicated Intra-Abdominal Infection Patients in Three Indonesian Referral Hospitals. Antibiotics, 12(1), 52. https://doi.org/10.3390/antibiotics12010052